A comparison of social prescribing approaches across twelve high-income countries
•Social prescribing is a way to direct patients to local, non-clinical services to assist them in improving their health and well-being.•Scale and scope of programmes vary significantly across the countries surveyed.•Social prescribing offers flexibility for adaptation to different contexts and need...
Gespeichert in:
Veröffentlicht in: | Health policy (Amsterdam) 2024-04, Vol.142, p.104992-104992, Article 104992 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 104992 |
---|---|
container_issue | |
container_start_page | 104992 |
container_title | Health policy (Amsterdam) |
container_volume | 142 |
creator | Scarpetti, Giada Shadowen, Hannah Williams, Gemma A. Winkelmann, Juliane Kroneman, Madelon Groenewegen, Peter P. De Jong, Judith D. Fronteira, Inês Augusto, Gonçalo Figueiredo Hsiung, Sonia Slade, Siân Rojatz, Daniela Kallayova, Daniela Katreniakova, Zuzana Nagyova, Iveta Kylänen, Marika Vracko, Pia Jesurasa, Amrita Wallace, Zoe Wallace, Carolyn Costongs, Caroline Barnes, Andrew J. van Ginneken, Ewout |
description | •Social prescribing is a way to direct patients to local, non-clinical services to assist them in improving their health and well-being.•Scale and scope of programmes vary significantly across the countries surveyed.•Social prescribing offers flexibility for adaptation to different contexts and needs.•Robust evidence on impact is limited and context-dependent, although there are indications of cost-effectiveness and a positive influence on health.
Social prescribing connects patients with community resources to improve their health and well-being. It is gaining momentum globally due to its potential for addressing non-medical causes of illness while building on existing resources and enhancing overall health at a relatively low cost. The COVID-19 pandemic further underscored the need for policy interventions to address health-related social issues such as loneliness and isolation.
This paper presents evidence of the conceptualisation and implementation of social prescribing schemes in twelve countries: Australia, Austria, Canada, England, Finland, Germany, Portugal, the Slovak Republic, Slovenia, the Netherlands, the United States and Wales.
Twelve countries were identified through the Health Systems and Policy Monitor (HSPM) network and the EuroHealthNet Partnership. Information was collected through a twelve open-ended question survey based on a conceptual model inspired by the WHO's Health System Framework.
We found that social prescribing can take different forms, and the scale of implementation also varies significantly. Robust evidence on impact is scarce and highly context-specific, with some indications of cost-effectiveness and positive impact on well-being.
This paper provides insights into social prescribing in various contexts and may guide countries interested in holistically tackling health-related social factors and strengthening community-based care. Policies can support a more seamless integration of social prescribing into existing care, improve collaboration among sectors and training programs for health and social care professionals. |
doi_str_mv | 10.1016/j.healthpol.2024.104992 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2928586157</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0168851024000022</els_id><sourcerecordid>2928586157</sourcerecordid><originalsourceid>FETCH-LOGICAL-c420t-3ceb41a0835c5c5ef8894f03fdbe6bfee205bfb46f6dda7925f08106fc456d3d3</originalsourceid><addsrcrecordid>eNqFkMtOwzAQRS0EoqXwC5AlmxQ_EsdZVhUvqRJCgrXlOOPGVRoHOyni73FpYYtmYWl05s74IHRD8Jxgwu828wZUOzS9a-cU0yx2s7KkJ2hKREFTjvPsFE0jKVKREzxBFyFsMMYFY_wcTZhgXHBOpuh1kWi37ZW3wXWJM0lw2qo26T0E7W1lu3Wi-t47pRsIidLehZAMn9DuIGnsukltFwMgpozd4C2ES3RmVBvg6vjO0PvD_dvyKV29PD4vF6tUZxQPKdNQZURhwXIdC4wQZWYwM3UFvDIAFOeVqTJueF2roqS5wYJgbnSW85rVbIZuD7nxuI8RwiC3NmhoW9WBG4OkJRW54CQvIloc0J_rPRjZe7tV_ksSLPc-5Ub--ZR7n_LgM05eH5eM1Rbqv7lfgRFYHACIX91Z8DJoC52G2nrQg6yd_XfJN0bWjM4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2928586157</pqid></control><display><type>article</type><title>A comparison of social prescribing approaches across twelve high-income countries</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Scarpetti, Giada ; Shadowen, Hannah ; Williams, Gemma A. ; Winkelmann, Juliane ; Kroneman, Madelon ; Groenewegen, Peter P. ; De Jong, Judith D. ; Fronteira, Inês ; Augusto, Gonçalo Figueiredo ; Hsiung, Sonia ; Slade, Siân ; Rojatz, Daniela ; Kallayova, Daniela ; Katreniakova, Zuzana ; Nagyova, Iveta ; Kylänen, Marika ; Vracko, Pia ; Jesurasa, Amrita ; Wallace, Zoe ; Wallace, Carolyn ; Costongs, Caroline ; Barnes, Andrew J. ; van Ginneken, Ewout</creator><creatorcontrib>Scarpetti, Giada ; Shadowen, Hannah ; Williams, Gemma A. ; Winkelmann, Juliane ; Kroneman, Madelon ; Groenewegen, Peter P. ; De Jong, Judith D. ; Fronteira, Inês ; Augusto, Gonçalo Figueiredo ; Hsiung, Sonia ; Slade, Siân ; Rojatz, Daniela ; Kallayova, Daniela ; Katreniakova, Zuzana ; Nagyova, Iveta ; Kylänen, Marika ; Vracko, Pia ; Jesurasa, Amrita ; Wallace, Zoe ; Wallace, Carolyn ; Costongs, Caroline ; Barnes, Andrew J. ; van Ginneken, Ewout</creatorcontrib><description>•Social prescribing is a way to direct patients to local, non-clinical services to assist them in improving their health and well-being.•Scale and scope of programmes vary significantly across the countries surveyed.•Social prescribing offers flexibility for adaptation to different contexts and needs.•Robust evidence on impact is limited and context-dependent, although there are indications of cost-effectiveness and a positive influence on health.
Social prescribing connects patients with community resources to improve their health and well-being. It is gaining momentum globally due to its potential for addressing non-medical causes of illness while building on existing resources and enhancing overall health at a relatively low cost. The COVID-19 pandemic further underscored the need for policy interventions to address health-related social issues such as loneliness and isolation.
This paper presents evidence of the conceptualisation and implementation of social prescribing schemes in twelve countries: Australia, Austria, Canada, England, Finland, Germany, Portugal, the Slovak Republic, Slovenia, the Netherlands, the United States and Wales.
Twelve countries were identified through the Health Systems and Policy Monitor (HSPM) network and the EuroHealthNet Partnership. Information was collected through a twelve open-ended question survey based on a conceptual model inspired by the WHO's Health System Framework.
We found that social prescribing can take different forms, and the scale of implementation also varies significantly. Robust evidence on impact is scarce and highly context-specific, with some indications of cost-effectiveness and positive impact on well-being.
This paper provides insights into social prescribing in various contexts and may guide countries interested in holistically tackling health-related social factors and strengthening community-based care. Policies can support a more seamless integration of social prescribing into existing care, improve collaboration among sectors and training programs for health and social care professionals.</description><identifier>ISSN: 0168-8510</identifier><identifier>EISSN: 1872-6054</identifier><identifier>DOI: 10.1016/j.healthpol.2024.104992</identifier><identifier>PMID: 38368661</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>Community referral ; COVID-19 ; Developed Countries ; England ; Humans ; Link worker ; Pandemics ; Person-centred care ; Social determinants of health ; Social prescribing ; Social Support ; United States</subject><ispartof>Health policy (Amsterdam), 2024-04, Vol.142, p.104992-104992, Article 104992</ispartof><rights>2024</rights><rights>Copyright © 2024. Published by Elsevier B.V.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c420t-3ceb41a0835c5c5ef8894f03fdbe6bfee205bfb46f6dda7925f08106fc456d3d3</citedby><cites>FETCH-LOGICAL-c420t-3ceb41a0835c5c5ef8894f03fdbe6bfee205bfb46f6dda7925f08106fc456d3d3</cites><orcidid>0000-0003-1243-196X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0168851024000022$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38368661$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Scarpetti, Giada</creatorcontrib><creatorcontrib>Shadowen, Hannah</creatorcontrib><creatorcontrib>Williams, Gemma A.</creatorcontrib><creatorcontrib>Winkelmann, Juliane</creatorcontrib><creatorcontrib>Kroneman, Madelon</creatorcontrib><creatorcontrib>Groenewegen, Peter P.</creatorcontrib><creatorcontrib>De Jong, Judith D.</creatorcontrib><creatorcontrib>Fronteira, Inês</creatorcontrib><creatorcontrib>Augusto, Gonçalo Figueiredo</creatorcontrib><creatorcontrib>Hsiung, Sonia</creatorcontrib><creatorcontrib>Slade, Siân</creatorcontrib><creatorcontrib>Rojatz, Daniela</creatorcontrib><creatorcontrib>Kallayova, Daniela</creatorcontrib><creatorcontrib>Katreniakova, Zuzana</creatorcontrib><creatorcontrib>Nagyova, Iveta</creatorcontrib><creatorcontrib>Kylänen, Marika</creatorcontrib><creatorcontrib>Vracko, Pia</creatorcontrib><creatorcontrib>Jesurasa, Amrita</creatorcontrib><creatorcontrib>Wallace, Zoe</creatorcontrib><creatorcontrib>Wallace, Carolyn</creatorcontrib><creatorcontrib>Costongs, Caroline</creatorcontrib><creatorcontrib>Barnes, Andrew J.</creatorcontrib><creatorcontrib>van Ginneken, Ewout</creatorcontrib><title>A comparison of social prescribing approaches across twelve high-income countries</title><title>Health policy (Amsterdam)</title><addtitle>Health Policy</addtitle><description>•Social prescribing is a way to direct patients to local, non-clinical services to assist them in improving their health and well-being.•Scale and scope of programmes vary significantly across the countries surveyed.•Social prescribing offers flexibility for adaptation to different contexts and needs.•Robust evidence on impact is limited and context-dependent, although there are indications of cost-effectiveness and a positive influence on health.
Social prescribing connects patients with community resources to improve their health and well-being. It is gaining momentum globally due to its potential for addressing non-medical causes of illness while building on existing resources and enhancing overall health at a relatively low cost. The COVID-19 pandemic further underscored the need for policy interventions to address health-related social issues such as loneliness and isolation.
This paper presents evidence of the conceptualisation and implementation of social prescribing schemes in twelve countries: Australia, Austria, Canada, England, Finland, Germany, Portugal, the Slovak Republic, Slovenia, the Netherlands, the United States and Wales.
Twelve countries were identified through the Health Systems and Policy Monitor (HSPM) network and the EuroHealthNet Partnership. Information was collected through a twelve open-ended question survey based on a conceptual model inspired by the WHO's Health System Framework.
We found that social prescribing can take different forms, and the scale of implementation also varies significantly. Robust evidence on impact is scarce and highly context-specific, with some indications of cost-effectiveness and positive impact on well-being.
This paper provides insights into social prescribing in various contexts and may guide countries interested in holistically tackling health-related social factors and strengthening community-based care. Policies can support a more seamless integration of social prescribing into existing care, improve collaboration among sectors and training programs for health and social care professionals.</description><subject>Community referral</subject><subject>COVID-19</subject><subject>Developed Countries</subject><subject>England</subject><subject>Humans</subject><subject>Link worker</subject><subject>Pandemics</subject><subject>Person-centred care</subject><subject>Social determinants of health</subject><subject>Social prescribing</subject><subject>Social Support</subject><subject>United States</subject><issn>0168-8510</issn><issn>1872-6054</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMtOwzAQRS0EoqXwC5AlmxQ_EsdZVhUvqRJCgrXlOOPGVRoHOyni73FpYYtmYWl05s74IHRD8Jxgwu828wZUOzS9a-cU0yx2s7KkJ2hKREFTjvPsFE0jKVKREzxBFyFsMMYFY_wcTZhgXHBOpuh1kWi37ZW3wXWJM0lw2qo26T0E7W1lu3Wi-t47pRsIidLehZAMn9DuIGnsukltFwMgpozd4C2ES3RmVBvg6vjO0PvD_dvyKV29PD4vF6tUZxQPKdNQZURhwXIdC4wQZWYwM3UFvDIAFOeVqTJueF2roqS5wYJgbnSW85rVbIZuD7nxuI8RwiC3NmhoW9WBG4OkJRW54CQvIloc0J_rPRjZe7tV_ksSLPc-5Ub--ZR7n_LgM05eH5eM1Rbqv7lfgRFYHACIX91Z8DJoC52G2nrQg6yd_XfJN0bWjM4</recordid><startdate>202404</startdate><enddate>202404</enddate><creator>Scarpetti, Giada</creator><creator>Shadowen, Hannah</creator><creator>Williams, Gemma A.</creator><creator>Winkelmann, Juliane</creator><creator>Kroneman, Madelon</creator><creator>Groenewegen, Peter P.</creator><creator>De Jong, Judith D.</creator><creator>Fronteira, Inês</creator><creator>Augusto, Gonçalo Figueiredo</creator><creator>Hsiung, Sonia</creator><creator>Slade, Siân</creator><creator>Rojatz, Daniela</creator><creator>Kallayova, Daniela</creator><creator>Katreniakova, Zuzana</creator><creator>Nagyova, Iveta</creator><creator>Kylänen, Marika</creator><creator>Vracko, Pia</creator><creator>Jesurasa, Amrita</creator><creator>Wallace, Zoe</creator><creator>Wallace, Carolyn</creator><creator>Costongs, Caroline</creator><creator>Barnes, Andrew J.</creator><creator>van Ginneken, Ewout</creator><general>Elsevier B.V</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-1243-196X</orcidid></search><sort><creationdate>202404</creationdate><title>A comparison of social prescribing approaches across twelve high-income countries</title><author>Scarpetti, Giada ; Shadowen, Hannah ; Williams, Gemma A. ; Winkelmann, Juliane ; Kroneman, Madelon ; Groenewegen, Peter P. ; De Jong, Judith D. ; Fronteira, Inês ; Augusto, Gonçalo Figueiredo ; Hsiung, Sonia ; Slade, Siân ; Rojatz, Daniela ; Kallayova, Daniela ; Katreniakova, Zuzana ; Nagyova, Iveta ; Kylänen, Marika ; Vracko, Pia ; Jesurasa, Amrita ; Wallace, Zoe ; Wallace, Carolyn ; Costongs, Caroline ; Barnes, Andrew J. ; van Ginneken, Ewout</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c420t-3ceb41a0835c5c5ef8894f03fdbe6bfee205bfb46f6dda7925f08106fc456d3d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Community referral</topic><topic>COVID-19</topic><topic>Developed Countries</topic><topic>England</topic><topic>Humans</topic><topic>Link worker</topic><topic>Pandemics</topic><topic>Person-centred care</topic><topic>Social determinants of health</topic><topic>Social prescribing</topic><topic>Social Support</topic><topic>United States</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Scarpetti, Giada</creatorcontrib><creatorcontrib>Shadowen, Hannah</creatorcontrib><creatorcontrib>Williams, Gemma A.</creatorcontrib><creatorcontrib>Winkelmann, Juliane</creatorcontrib><creatorcontrib>Kroneman, Madelon</creatorcontrib><creatorcontrib>Groenewegen, Peter P.</creatorcontrib><creatorcontrib>De Jong, Judith D.</creatorcontrib><creatorcontrib>Fronteira, Inês</creatorcontrib><creatorcontrib>Augusto, Gonçalo Figueiredo</creatorcontrib><creatorcontrib>Hsiung, Sonia</creatorcontrib><creatorcontrib>Slade, Siân</creatorcontrib><creatorcontrib>Rojatz, Daniela</creatorcontrib><creatorcontrib>Kallayova, Daniela</creatorcontrib><creatorcontrib>Katreniakova, Zuzana</creatorcontrib><creatorcontrib>Nagyova, Iveta</creatorcontrib><creatorcontrib>Kylänen, Marika</creatorcontrib><creatorcontrib>Vracko, Pia</creatorcontrib><creatorcontrib>Jesurasa, Amrita</creatorcontrib><creatorcontrib>Wallace, Zoe</creatorcontrib><creatorcontrib>Wallace, Carolyn</creatorcontrib><creatorcontrib>Costongs, Caroline</creatorcontrib><creatorcontrib>Barnes, Andrew J.</creatorcontrib><creatorcontrib>van Ginneken, Ewout</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Health policy (Amsterdam)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Scarpetti, Giada</au><au>Shadowen, Hannah</au><au>Williams, Gemma A.</au><au>Winkelmann, Juliane</au><au>Kroneman, Madelon</au><au>Groenewegen, Peter P.</au><au>De Jong, Judith D.</au><au>Fronteira, Inês</au><au>Augusto, Gonçalo Figueiredo</au><au>Hsiung, Sonia</au><au>Slade, Siân</au><au>Rojatz, Daniela</au><au>Kallayova, Daniela</au><au>Katreniakova, Zuzana</au><au>Nagyova, Iveta</au><au>Kylänen, Marika</au><au>Vracko, Pia</au><au>Jesurasa, Amrita</au><au>Wallace, Zoe</au><au>Wallace, Carolyn</au><au>Costongs, Caroline</au><au>Barnes, Andrew J.</au><au>van Ginneken, Ewout</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A comparison of social prescribing approaches across twelve high-income countries</atitle><jtitle>Health policy (Amsterdam)</jtitle><addtitle>Health Policy</addtitle><date>2024-04</date><risdate>2024</risdate><volume>142</volume><spage>104992</spage><epage>104992</epage><pages>104992-104992</pages><artnum>104992</artnum><issn>0168-8510</issn><eissn>1872-6054</eissn><abstract>•Social prescribing is a way to direct patients to local, non-clinical services to assist them in improving their health and well-being.•Scale and scope of programmes vary significantly across the countries surveyed.•Social prescribing offers flexibility for adaptation to different contexts and needs.•Robust evidence on impact is limited and context-dependent, although there are indications of cost-effectiveness and a positive influence on health.
Social prescribing connects patients with community resources to improve their health and well-being. It is gaining momentum globally due to its potential for addressing non-medical causes of illness while building on existing resources and enhancing overall health at a relatively low cost. The COVID-19 pandemic further underscored the need for policy interventions to address health-related social issues such as loneliness and isolation.
This paper presents evidence of the conceptualisation and implementation of social prescribing schemes in twelve countries: Australia, Austria, Canada, England, Finland, Germany, Portugal, the Slovak Republic, Slovenia, the Netherlands, the United States and Wales.
Twelve countries were identified through the Health Systems and Policy Monitor (HSPM) network and the EuroHealthNet Partnership. Information was collected through a twelve open-ended question survey based on a conceptual model inspired by the WHO's Health System Framework.
We found that social prescribing can take different forms, and the scale of implementation also varies significantly. Robust evidence on impact is scarce and highly context-specific, with some indications of cost-effectiveness and positive impact on well-being.
This paper provides insights into social prescribing in various contexts and may guide countries interested in holistically tackling health-related social factors and strengthening community-based care. Policies can support a more seamless integration of social prescribing into existing care, improve collaboration among sectors and training programs for health and social care professionals.</abstract><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>38368661</pmid><doi>10.1016/j.healthpol.2024.104992</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-1243-196X</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0168-8510 |
ispartof | Health policy (Amsterdam), 2024-04, Vol.142, p.104992-104992, Article 104992 |
issn | 0168-8510 1872-6054 |
language | eng |
recordid | cdi_proquest_miscellaneous_2928586157 |
source | MEDLINE; Elsevier ScienceDirect Journals |
subjects | Community referral COVID-19 Developed Countries England Humans Link worker Pandemics Person-centred care Social determinants of health Social prescribing Social Support United States |
title | A comparison of social prescribing approaches across twelve high-income countries |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T08%3A52%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20comparison%20of%20social%20prescribing%20approaches%20across%20twelve%20high-income%20countries&rft.jtitle=Health%20policy%20(Amsterdam)&rft.au=Scarpetti,%20Giada&rft.date=2024-04&rft.volume=142&rft.spage=104992&rft.epage=104992&rft.pages=104992-104992&rft.artnum=104992&rft.issn=0168-8510&rft.eissn=1872-6054&rft_id=info:doi/10.1016/j.healthpol.2024.104992&rft_dat=%3Cproquest_cross%3E2928586157%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2928586157&rft_id=info:pmid/38368661&rft_els_id=S0168851024000022&rfr_iscdi=true |